These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6090359)

  • 1. Tumor sensitization and protection: influence of stromal injury on estimates of dose modification.
    Williams MV; Rojas A; Denekamp J
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1545-9. PubMed ID: 6090359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor type, size, and endpoint on tumor radioprotection by WR-2721.
    Milas L; Hunter N; Ito H; Peters LJ
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):41-8. PubMed ID: 6321411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioprotection of mouse skin vasculature and the RIF-1 fibrosarcoma by WR-2721.
    Penhaligon M
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1541-4. PubMed ID: 6090358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined radiosensitization and radioprotection for oral cavity tumors: study with an oral cavity tumor model.
    Grigsby P; Maruyama Y
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):557-9. PubMed ID: 6286553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
    McNally NJ; Denekamp J; Sheldon P; Flockhart IR; Stewart FA
    Radiat Res; 1978 Mar; 73(3):568-80. PubMed ID: 273269
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
    Mendiondo OA; Grigsby PW; Beach JL
    Radiology; 1983 Jul; 148(1):291-3. PubMed ID: 6304811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ; de Ronde J; Hinchliffe M
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of the radiation response of the mouse kidney by misonidazole and WR-2721.
    Williams MV; Denekamp J
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1731-6. PubMed ID: 6315650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the ability of some radiosensitizers undergoing clinical trials to act as chemosensitizers.
    Hinchliffe M; McNally NJ
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1635-40. PubMed ID: 6237081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of environmental conditions (pH, oxygenation, and temperature) on misonidazole cytotoxicity and radiosensitization in vitro and in vivo in FSaIIC fibrosarcoma.
    Holden SA; Teicher BA; Herman TS
    Int J Radiat Oncol Biol Phys; 1991 May; 20(5):1031-8. PubMed ID: 2022503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
    Rojas A; Stewart FA; Denekamp J
    Br J Cancer; 1983 Jan; 47(1):65-72. PubMed ID: 6295429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retardation of tumor growth in mice caused by radiation-induced injury of tumor bed stroma: dependency on tumor type.
    Milas L; Ito H; Hunter N; Jones S; Peters LJ
    Cancer Res; 1986 Feb; 46(2):723-7. PubMed ID: 3940638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental radiotherapy with WR-2721 and misonidazole.
    Rojas A; Stewart FA; Denekamp J
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):527-30. PubMed ID: 6286547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation damage of normal tissues and a fibrosarcoma in mice.
    Milas L; Hunter N; Reid BO; Thames HD
    Cancer Res; 1982 May; 42(5):1888-97. PubMed ID: 6279288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitizers and protectors in clinical oncology.
    Phillips TL
    Semin Oncol; 1981 Mar; 8(1):65-82. PubMed ID: 6264627
    [No Abstract]   [Full Text] [Related]  

  • 17. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY; Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiosensitizing effects of misonidazole and SR 2508 on a human melanoma transplanted in nude mice: influence on repair of potentially lethal damage.
    Guichard M; Malaise EP
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):465-8. PubMed ID: 6213589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioprotection of two mouse tumors by WR-2721 in single and fractionated treatments.
    Stewart FA; Rojas A; Denekamp J
    Int J Radiat Oncol Biol Phys; 1983 Apr; 9(4):507-13. PubMed ID: 6303992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential radioprotection of normal tissues by hydrophilic chemical protectors.
    Brown DQ; Yuhas JM; MacKenzie LJ; Graham WJ; Pittock JW
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1581-4. PubMed ID: 6384158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.